EHRA Premium Access

Panel discussion

Congress Presentation

4 more presentations in this session

The trials-and-errors of antiarrhythmic drug therapy

Speaker: Professor J. Camm (London, GB)


Genetic basis for tailored drug therapy for ventricular arrhythmias

Speaker: Associate Professor C. Remme (Amsterdam, NL)


Rationale behind development of novel drugs for atrial arrhythmias

Speaker: Professor J. Heijman (Graz, AT)


Antiarrhythmic drugs - What, why, when to whom

Speaker: Professor G. Dan (Bucharest, RO)


Access the full session

Critical appraisal of antiarrhythmic drug therapy - The science behind trial-and-error

Speakers: Professor J. Camm, Associate Professor C. Remme, Professor J. Heijman, Professor G. Dan

About the event


EHRA 2019

17 March - 19 March 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb